Published Date: 02 Mar 2023
Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.
Read Full NewsBacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...
Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.
Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...
1.
Study finds primary-care doctors often overlook prostate cancer risk in Black men
2.
Sydney researchers identify new tools to improve cancer diagnosis and treatment.
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
5.
COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?
1.
The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure
2.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
3.
The Unseen Danger of Anal Cancer: How to Protect Yourself
4.
The Ins and Outs of Glossectomy: What You Need to Know
5.
The Pros and Cons of Steroid Therapy for ITP
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
3.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation